55 related articles for article (PubMed ID: 31822386)
1. Predicting resection margin status of pancreatic neuroendocrine tumors on CT: performance of NCCN resectability criteria.
Kim DH; Kim B; Chung DJ; Kim KA; Lee SL; Choi MH; Kim H; Rha SE
Br J Radiol; 2023 Dec; 96(1152):20230503. PubMed ID: 37750830
[TBL] [Abstract][Full Text] [Related]
2. PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
Qiu ZC; Wu YW; Qi WL; Li C
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38130028
[TBL] [Abstract][Full Text] [Related]
3. Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review.
Chen JW; Heidsma CM; Engelsman AF; Kabaktepe E; van Dieren S; Falconi M; Besselink MG; Nieveen van Dijkum EJM
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900316
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Clinicopathologic Features of Canine Metastatic Melanoma Involving the Central Nervous System: A Retrospective Analysis and Comparative Review.
Razmara AM; Wittenburg LA; Al-Nadaf S; Toedebusch RG; Meyers FJ; Toedebusch CM
Front Oncol; 2022; 12():868004. PubMed ID: 35692802
[TBL] [Abstract][Full Text] [Related]
5. Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors.
Ambrosini V; Zanoni L; Filice A; Lamberti G; Argalia G; Fortunati E; Campana D; Versari A; Fanti S
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205805
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer.
Gebauer L; Moltz JH; Mühlberg A; Holch JW; Huber T; Enke J; Jäger N; Haas M; Kruger S; Boeck S; Sühling M; Katzmann A; Hahn H; Kunz WG; Heinemann V; Nörenberg D; Maurus S
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830885
[TBL] [Abstract][Full Text] [Related]
7. Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study.
Heidsma CM; Tsilimigras DI; Rocha F; Abbott DE; Fields R; Poultsides GA; Cho CS; Lopez-Aguiar AG; Kanji Z; Fisher AV; Krasnick BA; Idrees K; Makris E; Beems M; van Eijck CHJ; Nieveen van Dijkum EJM; Maithel SK; Pawlik TM
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34067017
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
[TBL] [Abstract][Full Text] [Related]
9. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract][Full Text] [Related]
10. Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection.
Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
HPB (Oxford); 2020 Aug; 22(8):1149-1157. PubMed ID: 31822386
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model.
Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM
World J Surg; 2021 Jul; 45(7):2134-2141. PubMed ID: 33768309
[TBL] [Abstract][Full Text] [Related]
12. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
[TBL] [Abstract][Full Text] [Related]
13. Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma.
Endo Y; Sasaki K; Moazzam Z; Lima HA; Alaimo L; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2023-2032. PubMed ID: 36396868
[TBL] [Abstract][Full Text] [Related]
14. Interaction of margin status and tumour burden determines survival after resection of colorectal liver metastases: A retrospective cohort study.
Mao R; Zhao JJ; Bi XY; Zhang YF; Li ZY; Zhou JG; Zhao H; Cai JQ
Int J Surg; 2018 May; 53():371-377. PubMed ID: 29229309
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
